YAPALI, S. Et Al. 2022. Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis. International Liver Congress , (London, Canada).

YAPALI, S., GÖKCAN, H., Durak, S., Ellik, Z. M., Guzelbulut, F., Vatansever, S., ... Ari, D.(2022). Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis . International Liver Congress, London, Canada

YAPALI, Suna Et Al. "Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis," International Liver Congress, London, Canada, 2022

YAPALI, Suna Et Al. "Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis." International Liver Congress , London, Canada, 2022

YAPALI, S. Et Al. (2022) . "Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis." International Liver Congress , London, Canada.

@conferencepaper{conferencepaper, author={Suna YAPALI Et Al. }, title={Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis}, congress name={International Liver Congress}, city={London}, country={Canada}, year={2022}}